CCBasic Materials · Specialty ChemicalsThe 9 Wall Street analysts covering The Chemours Co. hold a median 12-month price target of $18 — +12.7% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 62 of 100 as at 21 Aug 2026 — in the upper half.
Consensus tells you what everyone already believes. The model scores The Chemours Co. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Accruals (90): Reported profit is backed by cash, and the company is not expanding recklessly.
Revisions (29): Analysts have, on balance, been cutting their forecasts.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on CC, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits +12.7% from it.
Of the 20 most recent actions, 0 moved their price target up and 6 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 13 Aug 2026 | BMO Capital | Maintains | Outperform | $26 → $18 |
| 13 Aug 2026 | JP Morgan | Maintains | Neutral | $22 → $15 |
| 10 Aug 2026 | UBS | Downgrade | Neutral | $29 → $18 |
| 6 Aug 2026 | RBC Capital | Maintains | Outperform | $26 → $22 |
| 6 Aug 2026 | Truist Securities | Maintains | Buy | $30 → $24 |
| 1 July 2026 | Mizuho | Maintains | Outperform | — |
| 1 July 2026 | Mizuho | Maintains | Outperform | $30 → $25 |
| 21 May 2026 | JP Morgan | Maintains | Neutral | — |
| 11 May 2026 | Morgan Stanley | Maintains | Equal-Weight | — |
| 11 May 2026 | RBC Capital | Maintains | Outperform | — |
| 8 May 2026 | UBS | Maintains | Buy | — |
| 28 Apr 2026 | Truist Securities | Maintains | Buy | — |
| 9 Apr 2026 | Truist Securities | Maintains | Buy | — |
| 9 Apr 2026 | UBS | Maintains | Buy | — |
| 5 Mar 2026 | Mizuho | Maintains | Outperform | — |
| 25 Feb 2026 | Goldman Sachs | Maintains | Neutral | — |
| 23 Feb 2026 | BMO Capital | Maintains | Outperform | — |
| 23 Feb 2026 | JP Morgan | Maintains | Neutral | — |
| 23 Feb 2026 | Morgan Stanley | Maintains | Equal-Weight | — |
| 23 Feb 2026 | UBS | Maintains | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CC appears on the weeks it earns a place.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 11% of US stocks
Cheaper than 85% of US stocks
Cheaper than 99% of US stocks
Cheaper than 32% of US stocks
Higher than 25% of US stocks
Higher than 34% of US stocks
Higher than 18% of US stocks
Higher than 47% of US stocks
Higher than 24% of US stocks
Higher than 5% of US stocks
Higher than 54% of US stocks
Higher than 49% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own The Chemours Co. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Chemours has expanded its low-GWP (global warming potential) Opteon refrigerant portfolio to address growing cooling demands from AI-driven data centers and support decarbonization efforts.
Why it matters — This positions Chemours to capture demand from the rapidly expanding data-center cooling market while aligning with global decarbonization goals.
Law Offices of Howard G. Smith announced an investigation into The Chemours Company on behalf of its investors concerning possible violations of federal securities laws. The firm is inviting Chemours shareholders who suffered losses to contact them about potentially pursuing claims to recover their losses.
Why it matters — CC watchers would care because the company is now subject to a securities fraud investigation that could lead to legal claims and regulatory scrutiny.
Chemours' second-quarter loss narrowed, but the company missed earnings and revenue estimates due to lower volumes and sales, and it outlined a cautious outlook for the third quarter.
Why it matters — CC watchers would care because lower volumes and sales weighed on quarterly results and the company flagged a cautious near-term outlook.
The Chemours Company announced the launch of Opteon™ ZE (R-1234ze(E)) and Opteon™ 515B (R-515B), two new refrigerants for stationary chiller applications. The products target AI-driven data centers, commercial HVAC, and other mission critical environments as high-performance, sustainable cooling solutions.
Why it matters — This expands Chemours' Opteon portfolio into the growing chiller and data center cooling market, potentially broadening its revenue base in sustainable refrigeration.
A federal judge approved more than $2.5 billion in settlements that New Jersey reached with DuPont, Chemours, Corteva and 3M to resolve PFAS pollution claims, also known as "forever chemicals."
Why it matters — Chemours is one of the settling parties in these approved PFAS-related settlements with New Jersey, resolving pollution claims against the company.
The 9 Wall Street analysts covering The Chemours Co. have a median 12-month price target of $18, with estimates ranging from $15 to $24. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 9 analysts covering The Chemours Co., 4 rate it a Buy, 5 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks The Chemours Co. 62 out of 100 across roughly 4,600 US stocks as at 21 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 21 Aug 2026, The Chemours Co. ranks 62 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (90 of 100).
No one can know that. What the data says: the median 12-month target from 9 analysts implies +12.7% from the last close, and Ticker Nerd's factor model ranks The Chemours Co. 62 out of 100 as at 21 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering The Chemours Co. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CC are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $15 to $24 over the next 12 months.
The Chemours Co. returned +15.3% over the 12 months to 21 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
Chemours Co. is an American specialty chemicals company headquartered in Wilmington, Delaware.
The most recent item we track (Zacks Investment Research, 14 Aug 2026): "Chemours Expands Low-GWP Refrigerant Portfolio for Data Centers". Chemours has expanded its low-GWP (global warming potential) Opteon refrigerant portfolio to address growing cooling demands from AI-driven data centers and support decarbonization efforts.
Chemours Co. is an American specialty chemicals company headquartered in Wilmington, Delaware. It focuses on performance chemicals used across industrial and consumer value chains, serving markets such as coatings, plastics, refrigeration and air conditioning, transportation, semiconductors, advanced electronics, oil and gas, and general industrial applications. Chemours Co. operates through three main business segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. Titanium Technologies produces titanium dioxide pigments that deliver whiteness, brightness, opacity, and durability for products like paints, plastics, and laminates. Thermal & Specialized Solutions provides refrigerants, thermal management solutions, propellants, blowing agents, and specialty solvents, marketed under brands such as Opteon and Freon. Advanced Performance Materials offers high-end polymers and advanced materials, including Teflon, Viton, Nafion, and Krytox, used in demanding applications in electronics, energy, transportation, and industrial processes. Today, Chemours Co. plays a significant role as a global business-to-business supplier of industrial and specialty chemistry, serving customers in roughly 110 countries.
CEO Ms. Denise M. Dignam · 5,700 employees · United States · https://www.chemours.com